Description

Retatrutide is a synthetic peptide engineered to interact with multiple metabolic receptor systems including GLP-1, GIP, and glucagon receptors. In laboratory studies, this compound is utilized for examining receptor binding dynamics and endocrine pathway signaling. Retatrutide is synthesized via solid-phase peptide synthesis and undergoes multi-stage purification to ensure high-purity analytical standards suitable for controlled research environments.

Specifications
Purity: ≥ 99% (Mass Spectrometry Verified)
Appearance: Lyophilized Solid
Format: Research Compound
Reconstitution: Recommended for laboratory titration using bacteriostatic water.

Notice
Mjolnir BIOTECH provides this compound as a reference material for scientific inquiry. All applications must be conducted by qualified professionals in controlled laboratory environments.

Sequence
39-residue GIP/GLP-1/glucagon triple agonist with Aib residues, α-Me-Leu, and a Lys-conjugated (AEEA)-γGlu-C20 diacid; C-terminal serinamide (per COA)

Soluble in bacteriostatic water; consult the product COA for specific solvent recommendations.

Store lyophilized at -20°C; protect from light and moisture. Reconstitute with bacteriostatic water; refrigerate reconstituted solution at 2-8°C.